Although the transgenic krasV12-induced HCC model was reported before6, and revealed several molecular mechanisms underlying kras driven liver tumorigenesis, as well as recapitulated the typical hallmarks of human HCC, the pathological mechanisms of nras mutations were less known. The gene discussed is NRAS; the disease is hepatocellular carcinoma.